4basebio (LON:4BB) Share Price Breaks Below Two Hundred Day Moving Average – Time to Sell?

4basebio PLC (LON:4BB)’s stock price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of GBX 523.96 and traded as low as GBX 509. 4basebio shares last traded at GBX 509, with a volume of 325 shares.

4basebio Stock Down 4.0%

The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The firm has a market capitalization of £78.82 million, a PE ratio of -4.39 and a beta of 1.09. The company has a fifty day moving average price of GBX 520.09 and a 200-day moving average price of GBX 523.96.

4basebio (LON:4BB) last posted its earnings results on Monday, September 28th. The company reported GBX (0.57) earnings per share for the quarter. As a group, analysts expect that 4basebio PLC will post -3.43 earnings per share for the current year.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.